These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


170 related items for PubMed ID: 19473587

  • 1. Scrotum and testicular calcinosis in juvenile dermatomyositis (JDM). A report of two cases.
    Sallum AM, Garcia AJ, Saito OC, Silva CA.
    Clin Exp Rheumatol; 2009; 27(2):382-3. PubMed ID: 19473587
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Calcinosis in juvenile dermatomyositis: a possible role for the vitamin K-dependent protein matrix Gla protein.
    van Summeren MJ, Spliet WG, van Royen-Kerkhof A, Vermeer C, Lilien M, Kuis W, Schurgers LJ.
    Rheumatology (Oxford); 2008 Mar; 47(3):267-71. PubMed ID: 18234711
    [Abstract] [Full Text] [Related]

  • 5. Hyperimmunoglobulin E syndrome with juvenile dermatomyositis and calcinosis.
    Saikia B, Aneja H, Jain J, Puliyel JM.
    Clin Rheumatol; 2013 Mar; 32 Suppl 1():S51-3. PubMed ID: 20373123
    [Abstract] [Full Text] [Related]

  • 6. Penile and scrotum swelling in juvenile dermatomyositis.
    Sallum AM, Silva MF, Michelin CM, Duarte RJ, Baroni RH, Aikawa NE, Silva CA.
    Acta Reumatol Port; 2011 Mar; 36(2):176-9. PubMed ID: 21841738
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for developing calcinosis in juvenile dermatomyositis: subcutaneous and myofascial edema in initial magnetic resonance imaging.
    Yi BY, Marrs J, Acharya P, Sura A, Cidon M.
    Rheumatol Int; 2024 Nov; 44(11):2577-2582. PubMed ID: 37432516
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pamidronate in Treatment of Calcinosis in Juvenile Dermatomyositis.
    Giri S, Parida JR, Dash M, Panda M.
    Indian Pediatr; 2020 Jan 15; 57(1):75-76. PubMed ID: 31937708
    [Abstract] [Full Text] [Related]

  • 10. The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.
    Hoeltzel MF, Oberle EJ, Robinson AB, Agarwal A, Rider LG.
    Curr Rheumatol Rep; 2014 Dec 15; 16(12):467. PubMed ID: 25366934
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications.
    Harel L, Harel G, Korenreich L, Straussberg R, Amir J.
    J Rheumatol; 2001 May 15; 28(5):1129-32. PubMed ID: 11361202
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vasculitis and calcinosis in juvenile dermatomyositis.
    Truckenbrodt H, Häfner R.
    Acta Univ Carol Med (Praha); 1991 May 15; 37(1-2):8-15. PubMed ID: 1845413
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy.
    Ambler GR, Chaitow J, Rogers M, McDonald DW, Ouvrier RA.
    J Rheumatol; 2005 Sep 15; 32(9):1837-9. PubMed ID: 16142885
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.